============================================================
Terminal Output Log - 2026-02-19
Agent: qwen3-max-10dollar-1
============================================================


============================================================
ğŸ“… LiveBench Daily Session: 2026-02-19
   Agent: qwen3-max-10dollar-1
============================================================

âœ… Task state updated: 74d6e8b0-f334-4e7e-af55-c095d5d4d1a6

ğŸ”„ Iteration 1/15
ğŸ’­ Agent: I need to analyze my current situation and decide whether to work or learn today.

Current status:
- Balance: $1339.94 (healthy, THRIVING status)
- Today's work task: Create comprehensive hormone ther...
ğŸ”§ Tool calls: 1

   ğŸ“ Calling: decide_activity
   ğŸ“¥ Args: {'activity': 'work', 'reasoning': "I have a healthy balance of $1339.94 and am in THRIVING status, m...
   âœ… Result: {'success': True, 'activity': 'work', 'reasoning': "I have a healthy balance of $1339.94 and am in THRIVING status, making me well-positioned to complete today's work task. The task involves creating hormone therapy prescribing guidelines for a menopause care platform, which is a well-defined deliverable that I can complete effectively. Completing this work will earn me up to $50, further strengthening my financial position while utilizing my research and documentation skills.", 'message': 'âœ… Decision made: WORK'}

ğŸ”„ Iteration 2/15
ğŸ’­ Agent: I need to complete the work task of creating comprehensive hormone therapy (HT) prescribing guidelines for the MenoHelp virtual menopause care platform. This requires:

1. Researching guidelines from ...
ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'NAMS North American Menopause Society hormone therapy guidelines 2025'}...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'NAMS North American Menopause Society hormone therapy guidelines 2025', 'answer': 'The NAMS guidelines recommend hormone therapy for symptom relief in healthy women up to age 60, with updated FDA warnings removed. Hormone therapy is advised until at least age 52 unless contraindicated. Breast cancer risk is slightly increased with long-term use.', 'results_count': 5, 'results': [{'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12438153/', 'title': 'The 2025 Menopausal Hormone Therapy Guidelines - PMC - NIH', 'content': 'MHT is the most effective treatment for VMS in healthy postmenopausal women who are 60 years old or younger and within 10 years of menopause. Symptom recurrence', 'score': 0.709684, 'raw_content': None}, {'url': 'https://www.affinitywholehealth.com/blog/hormone-therapy-breakthroughs-in-2025-for-men-and-women', 'title': "Hormone Therapy in 2025: A Recap of the Year's Biggest ...", 'content': '## Landmark Changes for Wome... (truncated)

ğŸ”„ Iteration 3/15
ğŸ’­ Agent: Now I'll search for additional international guidelines and more comprehensive information about hormone therapy prescribing protocols.


ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'international menopause society IMS hormone therapy guidelines 2025'}...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'international menopause society IMS hormone therapy guidelines 2025', 'answer': "The 2025 International Menopause Society guidelines emphasize the benefits of hormone therapy for reducing diabetes risk and improving cardiovascular health. They aim to ensure equitable access to evidence-based menopause management. The guidelines focus on the latest scientific findings for midlife women's health.", 'results_count': 5, 'results': [{'url': 'https://www.tandfonline.com/doi/full/10.1080/13697137.2025.2585487', 'title': 'International Menopause Society (IMS) recommendations and key ...', 'content': 'Throughout the document, the term menopause hormone therapy (MHT) has been used to cover therapies including estrogens, progestogens and combined therapies. In', 'score': 0.99998546, 'raw_content': None}, {'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12438153/', 'title': 'The 2025 Menopausal Hormone Therapy Guidelines - PMC - NIH', 'content': '... (truncated)

ğŸ”„ Iteration 4/15
ğŸ’­ Agent: Let me search for more specific information about contraindications, dosing protocols, and virtual care considerations for hormone therapy.


ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'hormone therapy contraindications dosing protocols virtual care menopause 2025'}...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'hormone therapy contraindications dosing protocols virtual care menopause 2025', 'answer': 'Contraindications for hormone therapy include breast cancer, blood clots, and liver disease. Dosing protocols vary by individual health status. Virtual care options are available for guidance on menopause hormone therapy in 2025.', 'results_count': 5, 'results': [{'url': 'https://www.youtube.com/watch?v=zSDzFb3lttA', 'title': 'FMDSA2025 Update on Menopause and Hormone Therapy', 'content': 'FMDSA 2025 Virtual Patient Meeting May 3, 2025. ... Three common side effects after starting on hormone replacement therapy and how to fix them.', 'score': 0.9996486, 'raw_content': None}, {'url': 'https://medicinetoday.com.au/system/files/pdf/MT2025-04-012-SZWARCBARD_0.pdf', 'title': '[PDF] Prescribing menopausal hormone therapy - Medicine Today', 'content': 'MENOPAUSAL MANAGEMENT FOR WOMEN IN MIDLIFE Stage Main aims Management* All women in midlife â€¢\tGeneral... (truncated)

ğŸ”„ Iteration 5/15
ğŸ’­ Agent: Now I'll search for specific information about different types of hormone therapy formulations and their appropriate use cases.


ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'types of hormone therapy formulations estradiol progesterone transdermal oral menopause 2...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'types of hormone therapy formulations estradiol progesterone transdermal oral menopause 2025', 'answer': 'Hormone therapy for menopause includes estradiol and progesterone in oral, transdermal, and patch forms. The most common type is estradiol, often delivered via patches or gels. The 2025 guidelines emphasize benefits and risks of these formulations.', 'results_count': 5, 'results': [{'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12438153/', 'title': 'The 2025 Menopausal Hormone Therapy Guidelines - PMC - NIH', 'content': 'Hormonal treatment options during this transitional phase include estrogen-progestogen therapy (EPT), low-dose combined oral contraceptives (COC), and oral or', 'score': 0.9998876, 'raw_content': None}, {'url': 'https://www.cancer.org/cancer/risk-prevention/medical-treatments/menopausal-hormone-replacement-therapy-and-cancer-risk.html', 'title': 'Menopausal Hormone Therapy and Cancer Risk', 'content': 'Estrogen i... (truncated)

ğŸ”„ Iteration 6/15
ğŸ’­ Agent: Let me search for information about monitoring protocols and follow-up care for patients on hormone therapy in virtual settings.


ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'monitoring follow-up protocols hormone therapy virtual menopause care 2025'}...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'monitoring follow-up protocols hormone therapy virtual menopause care 2025', 'answer': 'Follow-up for hormone therapy in menopause involves regular assessments every 1-2 years. Virtual care apps like emmii offer symptom tracking and guidance. The FDA will review menopause hormone therapy risks and benefits in 2025.', 'results_count': 5, 'results': [{'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12438153/', 'title': 'The 2025 Menopausal Hormone Therapy Guidelines - PMC', 'content': "by Y Kim Â· 2025 Â· Cited by 1 â€” These assessmentsâ€”both basic and electiveâ€”should be repeated every 1 to 2 years, depending on the patient's clinical status. MHT is indicated for alleviating", 'score': 0.999617, 'raw_content': None}, {'url': 'https://www.fda.gov/patients/fda-expert-panels/fda-expert-panel-menopause-and-hormone-replacement-therapy-women-07172025', 'title': 'FDA Expert Panel on Menopause and Hormone ...', 'content': '4. FDA Expert Panel on Men... (truncated)

ğŸ”„ Iteration 7/15
âš ï¸ Attempt 1 failed (TimeoutError), retrying in 0.5s...
   Error: API call timed out after 60.0 seconds
âš ï¸ Attempt 2 failed (TimeoutError), retrying in 1.0s...
   Error: API call timed out after 60.0 seconds

âŒ API call failed after 3 retries
   Error: API call timed out after 60.0 seconds
   â­ï¸ Skipping current task and continuing...

âš ï¸ Iteration limit reached without task completion
ğŸ”„ Initiating wrap-up workflow to collect artifacts...

============================================================
ğŸ”„ WRAP-UP WORKFLOW: Collecting and submitting artifacts
============================================================
ğŸ” Listing artifacts in E2B sandbox...
   ğŸ“¦ Connected to sandbox: None
   ğŸ” Scanning directory: /tmp
      Found 4 items in /tmp
   ğŸ” Scanning directory: /home/user
      Found 4 items in /home/user
   ğŸ” Scanning directory: /home/user/artifacts
      âš ï¸ Could not list /home/user/artifacts: path not found: lstat /home/user/artifacts: no such file or directory
   âš ï¸ No artifacts found in any directory
      Scanned: /tmp, /home/user, /home/user/artifacts
   No artifacts found to submit

============================================================
âœ… WRAP-UP WORKFLOW COMPLETE
============================================================


âš ï¸ Wrap-up workflow did not submit any work
ğŸ§¹ Cleaned up task sandbox
